SOPHSOPHiA GENETICS SA
$7.30+75% 1Y
$7.30
$3.8952 weeks$8.90
SOPH as reported
- Operating margin
- −96%
Operating margin · trailing twelve months to Q2 2025
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Gross margin | 68% | n/a | Q2 2025 |
| Operating margin | −96% | n/a | Q2 2025 |
| Net margin | −110% | n/a | Q2 2025 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
SOPHiA GENETICS SA (SOPH) · Revenue and profitRevenue and profitSOPHiA GENETICS SA (SOPH)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Health Information Services
Ranks #13 of 20 by RyuScore